Curaleaf Holdings Inc
CURA: XTSE (CAN)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
CAD 31.20 | Gxhhp | Vlgyxkddz |
Curaleaf's Long-Term Potential Shrouded by Near-Term Uncertainty Around Legalization Pace
Business Strategy and Outlook
Curaleaf cultivates and sells cannabis in the U.S. with a presence in 18 states. Vertically integrated, Curaleaf produces through 21 cultivation sites and sells directly through 146 dispensaries and wholesale to other dispensaries. Compared with other multistate operators, Curaleaf has generally employed a more aggressive growth strategy, which hasn't always paid off, leading to exits and sales.